HK Stock MarketDetailed Quotes

REGAL PARTNERS (01575)

Watchlist
  • 0.045
  • -0.002-4.26%
Market Closed May 15 15:58 CST
173.70MMarket Cap-1.80P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

REGAL PARTNERS (01575) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Turnover
-44.98%65.75M
-44.18%41.92M
-36.42%119.51M
-15.87%75.09M
42.39%187.98M
65.44%89.26M
-73.75%132.01M
-80.37%53.95M
-17.06%502.93M
29.38%274.88M
Operating income
-44.98%65.75M
-44.18%41.92M
-36.42%119.51M
-15.87%75.09M
42.39%187.98M
65.44%89.26M
-73.75%132.01M
-80.37%53.95M
-17.06%502.93M
29.38%274.88M
Cost of sales
31.43%-62.85M
43.98%-30.72M
22.66%-91.66M
13.89%-54.83M
8.85%-118.51M
-9.27%-63.68M
67.76%-130.01M
69.69%-58.28M
26.36%-403.28M
1.83%-192.24M
Operating expenses
31.43%-62.85M
43.98%-30.72M
22.66%-91.66M
13.89%-54.83M
8.85%-118.51M
-9.27%-63.68M
67.76%-130.01M
69.69%-58.28M
26.36%-403.28M
1.83%-192.24M
Gross profit
-89.58%2.9M
-44.74%11.2M
-59.91%27.85M
-20.78%20.26M
3,373.20%69.46M
691.22%25.58M
-97.99%2M
-105.23%-4.33M
69.58%99.66M
396.52%82.65M
Selling expenses
72.69%-9.01M
59.96%-8.4M
32.33%-32.98M
3.93%-20.98M
-34.12%-48.74M
-54.49%-21.84M
46.40%-36.34M
62.38%-14.13M
30.27%-67.8M
27.59%-37.57M
Administrative expenses
18.09%-37.49M
1.25%-22.05M
29.49%-45.77M
-12.38%-22.33M
56.97%-64.91M
82.26%-19.87M
-33.86%-150.84M
-72.61%-112.03M
-12.96%-112.69M
23.17%-64.9M
Revaluation surplus
----
----
83.36%-1.62M
----
---9.71M
----
----
----
----
----
-Changes in the fair value of financial assets
----
----
83.36%-1.62M
----
---9.71M
----
----
----
----
----
Impairment and provision
89.45%-7.08M
99.64%-217K
-105.85%-67.12M
-47,272.87%-61.11M
-70.12%-32.61M
97.62%-129K
-39.79%-19.17M
-2,020.70%-5.43M
34.10%-13.71M
-104.13%-256K
-Impairment of property, machinery and equipment
---1.3M
----
----
----
----
----
----
----
62.59%-4.85M
----
-Other impairment is provision
91.38%-5.79M
99.64%-217K
-105.85%-67.12M
-47,272.87%-61.11M
-70.12%-32.61M
97.62%-129K
-116.20%-19.17M
-2,020.70%-5.43M
-12.89%-8.87M
-104.13%-256K
Operating interest expense
----
----
----
----
----
----
----
---3.84M
----
----
Special items of operating profit
-130.57%-15.56M
170.87%90K
-31.58%50.88M
-101.90%-127K
781.83%74.37M
-51.79%6.68M
357.42%8.43M
224.51%13.86M
-103.69%-3.28M
-128.99%-11.13M
Operating profit
3.67%-66.23M
77.01%-19.38M
-466.28%-68.75M
-780.23%-84.28M
93.80%-12.14M
92.39%-9.58M
-100.29%-195.92M
-303.26%-125.9M
-39.24%-97.82M
58.44%-31.22M
Financing cost
-11.19%-22.12M
-36.67%-10.97M
-42.19%-19.89M
-58.58%-8.03M
-86.50%-13.99M
---5.06M
66.61%-7.5M
----
-27.73%-22.47M
17.72%-10.98M
Share of profits of associates
----
----
----
----
----
--4K
----
----
----
----
Earning before tax
0.33%-88.35M
67.12%-30.35M
-239.24%-88.64M
-530.80%-92.31M
87.15%-26.13M
88.38%-14.63M
-69.11%-203.42M
-198.34%-125.9M
-36.94%-120.29M
52.30%-42.2M
Tax
----
----
-2.94%66K
----
-91.83%68K
--71K
126.70%832K
----
-7.82%-3.12M
-160.46%-636K
After-tax profit from continuing operations
0.26%-88.35M
67.12%-30.35M
-239.87%-88.58M
-533.87%-92.31M
87.14%-26.06M
88.43%-14.56M
-64.17%-202.59M
-193.91%-125.9M
-36.01%-123.4M
51.00%-42.84M
Earning after tax
0.26%-88.35M
67.12%-30.35M
-239.87%-88.58M
-533.87%-92.31M
87.14%-26.06M
88.43%-14.56M
-64.17%-202.59M
-193.91%-125.9M
-36.01%-123.4M
51.00%-42.84M
Minority profit
-29.75%-1.2M
---1.47M
30.96%-921K
----
54.11%-1.33M
59.79%-766K
-53.48%-2.91M
-80.57%-1.91M
-509.96%-1.89M
-1,890.57%-1.06M
Profit attributable to shareholders
0.57%-87.15M
68.71%-28.89M
-254.48%-87.66M
-569.07%-92.31M
87.62%-24.73M
88.87%-13.8M
-64.33%-199.68M
-196.77%-123.99M
-33.24%-121.51M
52.18%-41.78M
Basic earnings per share
14.63%-0.028
71.88%-0.0097
-256.52%-0.0328
-563.46%-0.0345
93.42%-0.0092
95.67%-0.0052
-6.39%-0.1399
-165.49%-0.12
-37.55%-0.1315
49.55%-0.0452
Diluted earnings per share
14.63%-0.028
71.88%-0.0097
-256.52%-0.0328
-563.46%-0.0345
93.42%-0.0092
95.67%-0.0052
-6.39%-0.1399
-165.49%-0.12
-31.37%-0.1315
52.42%-0.0452
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Auditor
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Turnover -44.98%65.75M-44.18%41.92M-36.42%119.51M-15.87%75.09M42.39%187.98M65.44%89.26M-73.75%132.01M-80.37%53.95M-17.06%502.93M29.38%274.88M
Operating income -44.98%65.75M-44.18%41.92M-36.42%119.51M-15.87%75.09M42.39%187.98M65.44%89.26M-73.75%132.01M-80.37%53.95M-17.06%502.93M29.38%274.88M
Cost of sales 31.43%-62.85M43.98%-30.72M22.66%-91.66M13.89%-54.83M8.85%-118.51M-9.27%-63.68M67.76%-130.01M69.69%-58.28M26.36%-403.28M1.83%-192.24M
Operating expenses 31.43%-62.85M43.98%-30.72M22.66%-91.66M13.89%-54.83M8.85%-118.51M-9.27%-63.68M67.76%-130.01M69.69%-58.28M26.36%-403.28M1.83%-192.24M
Gross profit -89.58%2.9M-44.74%11.2M-59.91%27.85M-20.78%20.26M3,373.20%69.46M691.22%25.58M-97.99%2M-105.23%-4.33M69.58%99.66M396.52%82.65M
Selling expenses 72.69%-9.01M59.96%-8.4M32.33%-32.98M3.93%-20.98M-34.12%-48.74M-54.49%-21.84M46.40%-36.34M62.38%-14.13M30.27%-67.8M27.59%-37.57M
Administrative expenses 18.09%-37.49M1.25%-22.05M29.49%-45.77M-12.38%-22.33M56.97%-64.91M82.26%-19.87M-33.86%-150.84M-72.61%-112.03M-12.96%-112.69M23.17%-64.9M
Revaluation surplus --------83.36%-1.62M-------9.71M--------------------
-Changes in the fair value of financial assets --------83.36%-1.62M-------9.71M--------------------
Impairment and provision 89.45%-7.08M99.64%-217K-105.85%-67.12M-47,272.87%-61.11M-70.12%-32.61M97.62%-129K-39.79%-19.17M-2,020.70%-5.43M34.10%-13.71M-104.13%-256K
-Impairment of property, machinery and equipment ---1.3M----------------------------62.59%-4.85M----
-Other impairment is provision 91.38%-5.79M99.64%-217K-105.85%-67.12M-47,272.87%-61.11M-70.12%-32.61M97.62%-129K-116.20%-19.17M-2,020.70%-5.43M-12.89%-8.87M-104.13%-256K
Operating interest expense -------------------------------3.84M--------
Special items of operating profit -130.57%-15.56M170.87%90K-31.58%50.88M-101.90%-127K781.83%74.37M-51.79%6.68M357.42%8.43M224.51%13.86M-103.69%-3.28M-128.99%-11.13M
Operating profit 3.67%-66.23M77.01%-19.38M-466.28%-68.75M-780.23%-84.28M93.80%-12.14M92.39%-9.58M-100.29%-195.92M-303.26%-125.9M-39.24%-97.82M58.44%-31.22M
Financing cost -11.19%-22.12M-36.67%-10.97M-42.19%-19.89M-58.58%-8.03M-86.50%-13.99M---5.06M66.61%-7.5M-----27.73%-22.47M17.72%-10.98M
Share of profits of associates ----------------------4K----------------
Earning before tax 0.33%-88.35M67.12%-30.35M-239.24%-88.64M-530.80%-92.31M87.15%-26.13M88.38%-14.63M-69.11%-203.42M-198.34%-125.9M-36.94%-120.29M52.30%-42.2M
Tax ---------2.94%66K-----91.83%68K--71K126.70%832K-----7.82%-3.12M-160.46%-636K
After-tax profit from continuing operations 0.26%-88.35M67.12%-30.35M-239.87%-88.58M-533.87%-92.31M87.14%-26.06M88.43%-14.56M-64.17%-202.59M-193.91%-125.9M-36.01%-123.4M51.00%-42.84M
Earning after tax 0.26%-88.35M67.12%-30.35M-239.87%-88.58M-533.87%-92.31M87.14%-26.06M88.43%-14.56M-64.17%-202.59M-193.91%-125.9M-36.01%-123.4M51.00%-42.84M
Minority profit -29.75%-1.2M---1.47M30.96%-921K----54.11%-1.33M59.79%-766K-53.48%-2.91M-80.57%-1.91M-509.96%-1.89M-1,890.57%-1.06M
Profit attributable to shareholders 0.57%-87.15M68.71%-28.89M-254.48%-87.66M-569.07%-92.31M87.62%-24.73M88.87%-13.8M-64.33%-199.68M-196.77%-123.99M-33.24%-121.51M52.18%-41.78M
Basic earnings per share 14.63%-0.02871.88%-0.0097-256.52%-0.0328-563.46%-0.034593.42%-0.009295.67%-0.0052-6.39%-0.1399-165.49%-0.12-37.55%-0.131549.55%-0.0452
Diluted earnings per share 14.63%-0.02871.88%-0.0097-256.52%-0.0328-563.46%-0.034593.42%-0.009295.67%-0.0052-6.39%-0.1399-165.49%-0.12-31.37%-0.131552.42%-0.0452
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Auditor National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +2.64%
Sample Name
Sample Code
 -0.13%
Sample Name
Sample Code
 -1.05%
4
SHANGHAI PECHEM
00338
-1.56%
5
SINOPEC CORP
00386
-2.39%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +41.26%
Sample Name
Sample Code
 +31.66%
Sample Name
Sample Code
 +26.25%
4
Digital China Group
000034
+15.29%
5
Loongson Technology Corporation
688047
+12.74%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -